Intramembrane proteases as drug targets
- 6 January 2017
- journal article
- review article
- Published by Wiley in The FEBS Journal
- Vol. 284 (10) , 1489-1502
Abstract
Proteases are considered attractive drug targets. Various drugs targeting classical, soluble proteases have been approved for treatment of human disease. Intramembrane proteases (IMPs) are a more recently discovered group of proteolytic enzymes. They are embedded in lipid bilayers and their active sites are located in the plane of a membrane. All four mechanistic families of IMPs have been linked to disease, but currently, no drugs against IMPs have entered the market. In this review, I will outline the function of IMPs with a focus on the ones involved in human disease, which includes Alzheimer's disease, cancer, and infectious diseases by microorganisms. Inhibitors of IMPs are known for all mechanistic classes, but are not yet very potent or selective – aside from those targeting γ‐secretase. I will here describe the different features of IMP inhibitors and discuss a list of issues that need attention in the near future in order to improve the drug development for IMPs.Keywords
Funding Information
- KU Leuven
- Deutsche Forschungsgemeinschaft
This publication has 109 references indexed in Scilit:
- Structure of Rhomboid Protease in Complex with β-Lactam Inhibitors Defines the S2′ CavityStructure, 2013
- Conformational Change in Rhomboid Protease GlpG Induced by Inhibitor Binding to Its S′ SubsitesBiochemistry, 2012
- The mechanism of γ‐Secretase dysfunction in familial Alzheimer diseaseThe EMBO Journal, 2012
- Mitochondrial dynamics and mitophagy in Parkinson's disease: disordered cellular power plant becomes a big deal in a major movement disorderCurrent Opinion in Neurobiology, 2011
- Mammalian EGF receptor activation by the rhomboid protease RHBDL2EMBO Reports, 2011
- Monocyclic β-Lactams Are Selective, Mechanism-Based Inhibitors of Rhomboid Intramembrane ProteasesACS Chemical Biology, 2011
- The structural basis for catalysis and substrate specificity of a rhomboid proteaseThe EMBO Journal, 2010
- IFAP Syndrome Is Caused by Deficiency in MBTPS2, an Intramembrane Zinc Metalloprotease Essential for Cholesterol Homeostasis and ER Stress ResponseThe American Journal of Human Genetics, 2009
- Intramembrane ProteolysisChemical Reviews, 2009
- Drosophila Rhomboid-1 Defines a Family of Putative Intramembrane Serine ProteasesCell, 2001